Rush to Study Epigenetics of Cognitive Decline | GenomeWeb

NEW YORK (GenomeWeb News) – Rush University Medical Center in Chicago plans to use $5.5 million in grant funding from The National Institutes of Health to study how epigenetic changes may contribute to cognitive decline in older people, Rush said Wednesday.

Rush will conduct epigenome-wide DNA methylation scans and histone acetylation scans on brain tissue from participants in longitudinal studies of aging and dementia, including the Rush Memory and Aging Project and the Religious Orders Study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.